Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

Author： Yau Thomas   Pang Roberta   Chan Pierre   Poon Ronnie T  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.13, 2010-09, pp. : 2187-2198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma

By Zhu Andrew X  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 663-672

Informa Healthcare

Access to resources Recommend Favorite

Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy

By  

Journal of Digestive Diseases, Vol. 16, Iss. 9, 2015-09 ,pp. : 537-540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma

By  

Current Cancer Drug Targets, Vol. 16, Iss. 1, 2016-01 ,pp. : 53-70

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite